2014 Spring ADRC Meeting

Note: Following are links to available presentations from the meeting. The full agendas can be found here.

Administrators Meeting

Welcome and opening remarks
Dana Swenson-Dravis, MA; Chair, ADRC Administrators Steering Committee, Administrator, Mayo Clinic
Program income, price-setting, and cost recovery for biospecimen sharing
Virginia Buckles, PhD; Administrator, Washington University in St. Louis
ASSISTed living
Mary Sundsmo, MBA; Administrator, University of California, San Diego
Kathy Jedrziewski, PhD; Administrator, University of Pennsylvania
Clinical Trials in the Era of Prevention — Scientific symposium
Randall Bateman, MD
Director, Dominantly Inherited Alzheimer's Network Therapeutic Trials Unit (DIAN IU)
Jessica Langbaum, PhD
Associate Director, Alzheimer's Prevention Initiative (API)
Reisa Sperling, MD, MMSc — Project Leader, Anti-Amyloid Treatment in Asymptomatic AD — The "A4" Trial
Suzanne Craft, PhD — Project Leader, Study of Nasal Insulin to Fight Forgetfulness (SNIFF)

Directors Meeting

NIA update
Richard Hodes, MD; Director, NIA
NIA update
Neil S. Buckholtz, PhD; Director, Division of Neuroscience, NIA
NACC update
Walter A. Kukull, PhD; Director, National Alzheimer's Coordinating Center
ADGC update
Gerard Schellenberg, PhD; PI, Alzheimer's Disease Genetics Consortium
NCRAD update
Tatiana Foroud, PhD; PI, National Cell Repository for Alzheimer's Disease
NIAGADS update
Li-San Wang, PhD; PI, NIA Genetics of Alzheimer's Disease Data Storage Site
Clinical Task Force update
John C. Morris, MD; Chair, ADRC Clinical Task Force
National Alzheimer's Project Act (NAPA) update
Ronald C. Petersen, PhD, MD; Director, Mayo Clinic
Update on the revision to "NIA Biospecimen Best Practices Guidelines for the ADRCs"
Thomas J. Montine, MD, PhD; Director, University of Washington
BrainHealthRegistry.org — an internet-based portal for recruitment, assessment, screening, and longitudinal monitoring of subjects for clinical observationa or treatment trials
Michael W. Weiner, MD; PI, Alzheimer's Disease Neuroimaging Initiative
Junior Investigator Symposium — Introduction
Linda Van Eldik, PhD; Chair, ADRC Executive Committee
Early changes in the brain proteome associated with Alzheimer's disease risk
Nick Seyfried, PhD; Emory University
Integrating brain imaging and genetics to uncover risk for Alzheimer's disease
Robyn Honea, DPhil; University of Kansas

Clinical Core Leaders Meeting

UDS 3.0 update — review of protocol with changes from 12/13 teleconferences, and design of the crosswalk study
Sandra Weintraub, PhD; Clinical Core Leader, Northwestern University
UDS 3.0 crosswalk preliminary findings/results
Sarah Monsell, MS; Research Scientist, National Alzheimer's Coordinating Center
NACC imaging initiative update
Charles DeCarli, MD; Director, University of California, Davis
AD Lumbar Puncture Survey preliminary results
Krista Moulder, PhD; Associate Executive Director, Washington University in St. Louis